Literature DB >> 20541360

Quality of life outcomes in revision versus primary total knee arthroplasty.

Nelson V Greidanus1, Richard C Peterson, Bassam A Masri, Donald S Garbuz.   

Abstract

The purpose of this study was to evaluate and compare the quality of life and satisfaction outcomes of patients undergoing primary and revision total knee arthroplasty (TKA). Sixty revision and 199 primary TKA patients were assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Oxford-12 Knee Score, Short Form-12, and patient-reported satisfaction. Baseline preoperative scores demonstrate that revision TKA patients have inferior quality of life across all measures (WOMAC, Oxford-12, and Short Form-12) in comparison with primary TKA patients (P < .05). At follow-up revision, TKA patients continue to have inferior outcomes (P < .05) in comparison with primary TKA patients. When adjusting for confounding factors in regression analyses, revisions are inferior to primary TKA by 8.6 (95% confidence interval, 2.7-14.6) normalized WOMAC units.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20541360     DOI: 10.1016/j.arth.2010.04.026

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  31 in total

1.  Predictors of pain medication use for arthroplasty pain after revision total knee arthroplasty.

Authors:  Jasvinder A Singh; David G Lewallen
Journal:  Rheumatology (Oxford)       Date:  2014-01-22       Impact factor: 7.580

Review 2.  The use of postoperative suction drainage in total knee arthroplasty: a systematic review.

Authors:  Mark Quinn; Andrea Bowe; Rose Galvin; Peter Dawson; John O'Byrne
Journal:  Int Orthop       Date:  2014-07-16       Impact factor: 3.075

3.  Sports activity is maintained or increased following total knee arthroplasty.

Authors:  Caroline Hepperger; Peter Gföller; E Abermann; Christian Hoser; Hanno Ulmer; Elmar Herbst; Christian Fink
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-03-24       Impact factor: 4.342

4.  Use of complementary and alternative medicine among patients with radiographic-confirmed knee osteoarthritis.

Authors:  K L Lapane; M R Sands; S Yang; T E McAlindon; C B Eaton
Journal:  Osteoarthritis Cartilage       Date:  2011-10-14       Impact factor: 6.576

5.  Functional outcome following aseptic single-stage revision knee arthroplasty.

Authors:  Ajay Malviya; Nigel T Brewster; Karen Bettinson; James P Holland; David J Weir; David J Deehan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-22       Impact factor: 4.342

6.  Have the Causes of Revision for Total and Unicompartmental Knee Arthroplasties Changed During the Past Two Decades?

Authors:  Gro S Dyrhovden; Stein Håkon L Lygre; Mona Badawy; Øystein Gøthesen; Ove Furnes
Journal:  Clin Orthop Relat Res       Date:  2017-03-15       Impact factor: 4.176

7.  The Value of Total Knee Replacement in Patients With Knee Osteoarthritis and a Body Mass Index of 40 kg/m2 or Greater : A Cost-Effectiveness Analysis.

Authors:  Angela T Chen; Corin I Bronsther; Elizabeth E Stanley; A David Paltiel; James K Sullivan; Jamie E Collins; Tuhina Neogi; Jeffrey N Katz; Elena Losina
Journal:  Ann Intern Med       Date:  2021-03-23       Impact factor: 25.391

Review 8.  [Satisfaction after total knee arthroplasty. Comparison of 1990-1999 with 2000-2012].

Authors:  A Schulze; H P Scharf
Journal:  Orthopade       Date:  2013-10       Impact factor: 1.087

Review 9.  Osteolysis around total knee arthroplasty: a review of pathogenetic mechanisms.

Authors:  J Gallo; S B Goodman; Y T Konttinen; M A Wimmer; M Holinka
Journal:  Acta Biomater       Date:  2013-05-10       Impact factor: 8.947

10.  Gender-specific correlates of complementary and alternative medicine use for knee osteoarthritis.

Authors:  Rachel Jawahar; Shibing Yang; Charles B Eaton; Timothy McAlindon; Kate L Lapane
Journal:  J Womens Health (Larchmt)       Date:  2012-09-04       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.